Reuben, Alexandre http://orcid.org/0000-0003-4510-0382
Spencer, Christine N.
Prieto, Peter A.
Gopalakrishnan, Vancheswaran
Reddy, Sangeetha M.
Miller, John P.
Mao, Xizeng
De Macedo, Mariana Petaccia
Chen, Jiong
Song, Xingzhi
Jiang, Hong
Chen, Pei-Ling
Beird, Hannah C.
Garber, Haven R.
Roh, Whijae
Wani, Khalida
Chen, Eveline
Haymaker, Cara http://orcid.org/0000-0002-1317-9287
Forget, Marie-Andrée
Little, Latasha D.
Gumbs, Curtis
Thornton, Rebecca L.
Hudgens, Courtney W. http://orcid.org/0000-0001-8312-7485
Chen, Wei-Shen
Austin-Breneman, Jacob
Sloane, Robert Szczepaniak http://orcid.org/0000-0002-4106-8330
Nezi, Luigi
Cogdill, Alexandria P. http://orcid.org/0000-0001-8917-9462
Bernatchez, Chantale
Roszik, Jason
Hwu, Patrick
Woodman, Scott E.
Chin, Lynda
Tawbi, Hussein
Davies, Michael A.
Gershenwald, Jeffrey E.
Amaria, Rodabe N.
Glitza, Isabella C.
Diab, Adi
Patel, Sapna P.
Hu, Jianhua
Lee, Jeffrey E.
Grimm, Elizabeth A.
Tetzlaff, Michael T.
Lazar, Alexander J.
Wistuba, Ignacio I.
Clise-Dwyer, Karen
Carter, Brett W.
Zhang, Jianhua
Futreal, P. Andrew
Sharma, Padmanee
Allison, James P.
Cooper, Zachary A.
Wargo, Jennifer A.
Article History
Received: 31 October 2016
Revised: 27 February 2017
Accepted: 8 March 2017
First Online: 7 April 2017
Competing interests
: J.A.W. has honoraria from speakers’ bureau of Dava Oncology, and is an advisory board member for GlaxoSmithKline and Roche/Genentech. Z.A.C. is an employee of MedImmune and owns stock or options in AstraZeneca. M.A.D. is an advisory board member for GlaxoSmithKline, Roche/Genentech, Novartis and Sanofi-Aventis, and has received research support from GlaxoSmithKline, Roche/Genentech, Sanofi-Aventis, Oncothyreon, Myriad, and AstraZeneca. J.E.G. is on the advisory board of Merck, and receives royalties from Mercator Therapeutics. S.P.P. has honoraria from speakers’ bureau of Dava Oncology, Merck and Bristol-Myers Squibb, and is an advisory board member for Amgen and Roche/Genentech. P.H. serves on the advisory board of Lion Biotechnologies and Immatics US. R.N.A. has received research support from Merck, Novartis and Bristol-Myers Squibb. I.I.W. receives honoraria from Genentech/Roche, Ventana, GlaxoSmithKline, Celgene, Bristol-Myers Squibb, Synta Pharmaceuticals, Boehringer Ingelheim, Medscape, Clovis, AstraZeneca and Pfizer, and research support from Genentech/Roche, Oncoplex, and HGT. P.S. is a consultant for Bristol-Myers Squibb, Jounce Therapeutics, Helsinn, and GlaxoSmithKline as well as a stockholder from Jounce Therapeutics. J.P.A. is a consultant and stockholder for Jounce Therapeutics, receives royalties from Bristol-Myers Squibb, and has intellectual property with Bristol-Myers Squibb and Merck. The other authors declare that they have no competing interests.